CNSP
CNS Pharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CNSP fundamentals
CNS Pharmaceuticals (CNSP) released its earnings on Aug 14, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was -6.42 (YoY +4.46%), missed estimates.
Revenue / YoY
--
0.00%
EPS / YoY
-6.42
+4.46%
Report date
Aug 14, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
CNS Pharmaceuticals (CNSP) key financial stats and ratios, covering profitability, financial health, and leverage.
CNS Pharmaceuticals (CNSP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
CNS Pharmaceuticals (CNSP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
CNS Pharmaceuticals (CNSP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does CNS Pharmaceuticals (CNSP) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track CNS Pharmaceuticals (CNSP) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
Did CNS Pharmaceuticals beat or miss consensus estimates last quarter?What guidance did CNS Pharmaceuticals's management provide for the next earnings period?What is CNS Pharmaceuticals's gross profit margin?What factors drove the changes in CNS Pharmaceuticals's revenue and profit?What is CNS Pharmaceuticals's latest dividend and current dividend yield?What were the key takeaways from CNS Pharmaceuticals’s earnings call?What were the key takeaways from CNS Pharmaceuticals's earnings call?What is the revenue and EPS growth rate for CNS Pharmaceuticals year over year?
